ClinVar Miner

Submissions for variant NM_003718.5(CDK13):c.2525A>G (p.Asn842Ser)

dbSNP: rs878853160
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 23
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology RCV000417211 SCV000281758 pathogenic Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 2016-05-12 criteria provided, single submitter research
GeneDx RCV000498452 SCV000589447 pathogenic not provided 2022-08-31 criteria provided, single submitter clinical testing Not observed in large population cohorts (gnomAD); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 28554332, 28867141, 29393965, 31883531, 27479907, 28807008, 29021403, 29222009, 28135719, 24999027, 19344873, 25560765, 28991257, 31238879, 31036916, 29738522, 32277047, 32368696, 32901917, 31785789)
Ambry Genetics RCV000622786 SCV000742245 pathogenic Inborn genetic diseases 2017-03-15 criteria provided, single submitter clinical testing
Laboratory of Molecular Genetics (Pr. Bezieau's lab), CHU de Nantes RCV000498452 SCV000920567 pathogenic not provided 2018-09-14 criteria provided, single submitter clinical testing
Equipe Genetique des Anomalies du Developpement, Université de Bourgogne RCV000850464 SCV000992662 likely pathogenic Marfanoid habitus and intellectual disability criteria provided, single submitter research
CeGaT Center for Human Genetics Tuebingen RCV000498452 SCV001250331 pathogenic not provided 2021-11-01 criteria provided, single submitter clinical testing
Equipe Genetique des Anomalies du Developpement, Université de Bourgogne RCV000417211 SCV001439317 pathogenic Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 2020-07-22 criteria provided, single submitter clinical testing
Equipe Genetique des Anomalies du Developpement, Université de Bourgogne RCV001526523 SCV001736945 pathogenic Global developmental delay criteria provided, single submitter clinical testing
3billion RCV000417211 SCV002012180 pathogenic Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 2021-10-02 criteria provided, single submitter clinical testing Same nucleotide change resulting in same amino acid change has been previously reported as de novoo in a similarly affected individual (ClinVar ID: VCV000235887.20, PMID: 27479907 and 29021403, PS1, PS2 and PS4_M). The missense variant is located in a mutational hot spot and/or well-established functional domain in which established pathogenic variants have been reported (PM1). It is not observed in the gnomAD v2.1.1 dataset (PM2). A different missense change at the same codon (p.Asn842Asp) has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000522794.5, PMID: 28807008, 29021403, PM5). The variant was observed as assumed (i.e. paternity and maternity not confirmed) de novoo (3billion dataset, PM6). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.861, 3Cnet: 0.997, PP3). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.
Genetics and Molecular Pathology, SA Pathology RCV000417211 SCV002556994 pathogenic Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 2021-05-12 criteria provided, single submitter clinical testing The CDK13 c.2525A>G variant is classified as PATHOGENIC (PS4, PS2, PP3) The CDK13 c.2525A>G variant is a single nucleotide change in exon 6 of the CDK13 gene, which is predicted to change the amino acid asparagine at position 842 in the protein to serine. This recurrent variant has been identified in multiple individuals with global developmental delay or intellectual disability and dysmorphic features, with or without congenital heart defects, hypotonia or hearing loss (PMID:27479907, PMID:29021403, PMID:29222009) (PS4). A number of these cases have been shown to be de novo (PMID:28807008) (PS2). This variant is in dbSNP (rs878853160) but is absent from population databases (PM2). This variant has been reported in ClinVar as Pathogenic by multiple other diagnostic laboratories (Variation ID:235887), and has been reported as damaging for congenital heart disease, developmental delay and intellectual disability in HGMD (CM1610451). Computational predictions support a deleterious effect on the gene or gene product (PP3).
MGZ Medical Genetics Center RCV000417211 SCV002578968 pathogenic Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 2022-04-22 criteria provided, single submitter clinical testing
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute RCV000417211 SCV002769358 pathogenic Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 2022-02-02 criteria provided, single submitter clinical testing Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0105 - The mechanism of disease for this gene is not clearly established. However, haploinsufficiency, dominant negative and gain of function have been suggested in the literature (PMIDs: 30904094, 29393965, 28807008) (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from asparagine to serine. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0602 - Variant is located in a hotspot region or cluster of pathogenic variants. This variant is located in the protein kinase domain (PDB), where disease-associated missense variants are clustered (DECIPHER). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. The variant has been reported in many patients and shown to be de novo in multiple patients (ClinVar, Deciphering Developmental Disorders (DDD) Study). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign
Fulgent Genetics, Fulgent Genetics RCV000417211 SCV002815704 pathogenic Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 2021-09-22 criteria provided, single submitter clinical testing
Invitae RCV000498452 SCV003439941 pathogenic not provided 2022-10-18 criteria provided, single submitter clinical testing This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CDK13 protein function. ClinVar contains an entry for this variant (Variation ID: 235887). This missense change has been observed in individual(s) with CDK13-related conditions (PMID: 28807008). In at least one individual the variant was observed to be de novo. This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 842 of the CDK13 protein (p.Asn842Ser).
Baylor Genetics RCV000417211 SCV003835390 pathogenic Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 2022-08-12 criteria provided, single submitter clinical testing
OMIM RCV000417211 SCV000503042 pathogenic Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 2024-02-15 no assertion criteria provided literature only
GeneReviews RCV000417211 SCV001370887 not provided Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder no assertion provided literature only
Department of Genetics, Rouen University Hospital, Normandy Center for Genomic and Personalized Medicine RCV000417211 SCV001442986 pathogenic Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 2020-06-10 no assertion criteria provided clinical testing
Service de Génétique Moléculaire, Hôpital Robert Debré RCV000417211 SCV001450704 pathogenic Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 2020-09-03 no assertion criteria provided clinical testing
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000498452 SCV001741783 pathogenic not provided no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, Amsterdam University Medical Center RCV000498452 SCV001806804 pathogenic not provided no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000498452 SCV001956718 pathogenic not provided no assertion criteria provided clinical testing
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) RCV000498452 SCV002036802 pathogenic not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.